Drug-resistant Streptococcus pneumoniae and Methicillin-resistant Staphylococcus aureus Surveillance
2003

Surveillance of Drug-Resistant Infections

Sample size: 120 publication Evidence: moderate

Author Information

Author(s): Hawley Leigh Ann, Fridkin Scott K., Whitney Cynthia G.

Primary Institution: Centers for Disease Control and Prevention

Hypothesis

How can state-based surveillance of drug-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus be improved?

Conclusion

The conference highlighted the need for effective state-based surveillance to monitor drug-resistant infections and improve public health responses.

Supporting Evidence

  • Drug-resistant infections are a growing public health concern.
  • Effective surveillance can help track and manage these infections.
  • Local data collection is essential for informing treatment guidelines.

Takeaway

This study is about how health experts are trying to keep track of germs that don't get killed by medicine, so they can help people stay healthy.

Methodology

The conference involved discussions on surveillance methods and challenges faced by state health departments.

Potential Biases

Potential communication breakdowns between laboratories and health departments may introduce bias.

Limitations

The lack of resources for surveillance has challenged state public health agencies.

Participant Demographics

Participants included epidemiologists and health officials from 38 states.

Digital Object Identifier (DOI)

10.3201/eid0910.030454

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication